Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors.
about
Oral substitution treatment of injecting opioid users for prevention of HIV infectionSubstitution treatment of injecting opioid users for prevention of HIV infectionUnsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.Temporal and gender trends in concordance of urine drug screens and self-reported use in cocaine treatment studies.HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.Factors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment.Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.Measurement of self-reported HIV risk behaviors in injection drug users: comparison of standard versus timeline follow-back administration procedures.Validity of self-reported drug use in high risk populations: a meta-analytical review.Recommendations for incorporating human immunodeficiency virus (HIV) prevention into the medical care of persons living with HIV.Association between alcohol consumption and injection and sexual risk behaviors among people who inject drugs in rural Puerto Rico.Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, CanadaAdaptation and validation of a questionnaire about risk behaviors for AIDS among drug usersHospitalization for depressive syndrome in a cohort of HIV-infected patients contaminated through injecting drug use: MANIF 2000 cohort, France, 1995-1999Injecting Drug Users who Want Treatment
P2860
Q24234956-48C97690-A7F0-4580-BDF6-0C14EAF17851Q24243272-85E28E18-99CE-48BB-B47A-4CE1A8A7AE73Q28347851-C93D4580-B7DB-4F02-8359-A985D41C01A8Q33576025-6464E5A9-056C-4A22-A4CA-44FD7BAF902AQ33704262-BE9A62D2-FAD3-4D90-BB47-353F50066367Q34498325-F9C0C069-F391-4D98-BD82-0A8299939641Q36273083-F18CC42A-6930-4E7F-BA32-E65ABB93B249Q37114061-55FA12C6-0EEB-41EF-A9D8-D49490CDE5BDQ37463573-4B7B61DE-4748-4D7E-92A6-E82537C09D22Q41148641-3745B493-3F2C-4FFC-BAC8-B8DAEC5A29A2Q45703854-0B72EA03-F80F-4F51-97A1-1399A3B006A4Q50095599-C7ADF845-075C-4197-93FE-1BDB8E7749CBQ51971535-C27AC3A6-5ABE-4CD1-A5F2-7EC4D48C2ADFQ57672090-4CB6B4B0-05C1-449E-8123-B397365151F8Q58100185-EDED8C32-E309-45F6-BA0A-ED6D888C9864Q58266382-0573760D-6405-4010-8846-3637CD241727Q58309118-BF2A36D7-1184-4476-A579-D266010A9470
P2860
Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Validity of intravenous drug a ...... high-risk drug use behaviors.
@en
Validity of intravenous drug a ...... high-risk drug use behaviors.
@nl
type
label
Validity of intravenous drug a ...... high-risk drug use behaviors.
@en
Validity of intravenous drug a ...... high-risk drug use behaviors.
@nl
prefLabel
Validity of intravenous drug a ...... high-risk drug use behaviors.
@en
Validity of intravenous drug a ...... high-risk drug use behaviors.
@nl
P2093
P1476
Validity of intravenous drug a ...... high-risk drug use behaviors.
@en
P2093
Bigelow GE
Brooner RK
Greenfield L
P356
10.1016/0376-8716(95)01155-R
P577
1995-08-01T00:00:00Z